Market Closed -
Other stock markets
|
After market 19:53:41 | |||
13.6 EUR | +6.25% | 13.6 | +0.01% |
04-23 | ORPEA : Partial integration of the FY23 results | |
04-19 | ORPEA : Ready for a refoundation full of thorns |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company appears to be poorly valued given its net asset value.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company has insufficient levels of profitability.
- One of the major weak points of the company is its financial situation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Most analysts recommend that the stock should be sold or reduced.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.53% | 2.18B | B- | ||
-1.48% | 1.41B | - | C+ | |
-26.82% | 1.37B | - | ||
+18.30% | 1.32B | B | ||
+16.71% | 706M | - | B | |
-2.73% | 464M | B- | ||
+236.85% | 432M | - | D+ | |
-7.77% | 322M | - | - | |
+4.44% | 124M | B | ||
+39.04% | 88.82M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ORP Stock
- Ratings ORPEA